In support of this hypothesis, IL-6ST knockdown largely abrogated the promoting effects of FXR on Jak2/STAT3 signal activation and the following migration, invasion, and angiogenesis in NSCLC. This evidence concerns the gene JAK2 and non-small cell lung carcinoma.